Gene therapy for Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests a new gene therapy that may improve movement control in people with Parkinson's disease. It involves a one-time surgical injection into the brain and requires you to be off your usual Parkinson's medications during some assessments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 70 years old.
- You have had Parkinson's disease for at least 5 years but less than 15 years.
- Your Parkinson's symptoms are moderate to severe, and you respond well to levodopa (at least 30% improvement).
- Your Parkinson's medications have been stable for the past 3 months.
- You agree to have a surgical injection into the brain and to stay in the hospital for the procedure.
- You are willing to use effective contraception (but not birth control pills) for at least 6 months after the trial, if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental gene therapy delivered to a specific brain area to help control Parkinson's symptoms. It is for people with advanced Parkinson's whose current medications no longer work well enough.
This trial tests an experimental gene therapy injected directly into the brain, designed for people with Parkinson's disease who carry a specific genetic change called GBA1. The goal is to see if the treatment is safe, tolerable, and helps improve motor symptoms.
This trial tests a new gene therapy for Parkinson's disease. The therapy is delivered directly into the brain during a surgical procedure, with the goal of improving motor symptoms and reducing 'off' time.
This study tests a new cell therapy called bemdaneprocel to see if it can reduce Parkinson's symptoms and “off” time. The treatment involves transplanting special cells into the brain to help replace lost dopamine-producing cells.
This trial tests a new type of gene therapy for Parkinson's disease. It aims to make blocking cells more responsive, improving movement control and reducing symptoms.
This trial tests a new gene therapy delivered directly into the brain to help control Parkinson's symptoms. It is for people with advanced Parkinson's disease who still have significant movement problems despite their current medications.
Hear when a new Parkinsonian Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.